UCSF

Area

CRISPR

Services

Public Relations

VISIT THE SITE

UCSF / UC Berkeley / IGI / Gladstone Institutes scientists are ushering in a new era of curing rare diseases using CRISPR-Cas9.

Challenge

How do you communicate a visionary new approach to edit the genomes of patients with rare genetic mutations to slow or halt progression of their diseases?

Approach

We partnered with the communications, digital video, and scientific teams at UC San Francisco, UC Berkeley, Innovative Genomics Institute, and Gladstone Institutes to explain using CRISPR-Cas9 customized to individual patients. Such “bespoke” therapies can benefit small groups of individuals or families with particular genetic defects that would never be addressed by large pharmaceutical companies.

Impact

Through media coverage in elite science media such as WIRED and an educational video featuring the prominent scientists involved, the potential of this exciting breakthroughs is causing excitement and hope in rare diseases communities.

This is a unique website which will require a more modern browser to work!

Please upgrade today!